{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T07:42:19Z","timestamp":1771573339772,"version":"3.50.1"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["PROCAD AMAZ\u00d4NIA 88881.200581\/201801."],"award-info":[{"award-number":["PROCAD AMAZ\u00d4NIA 88881.200581\/201801."]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:p>Hemophilia is a recessive genetic disease caused by a mutation on the X chromosome that has been linked to a high risk of transfusion<jats:italic>-<\/jats:italic>transmitted infections, especially sexually transmitted infections. The purpose of this retrospective study was to characterize the clinical and epidemiological profile and describe the prevalence of sexually transmitted viral infections in patients with hemophilia in the Northern Brazilian state of Amazonas. We assessed clinical, laboratory and sociodemographic data of hemophiliac patients (<jats:italic>n<\/jats:italic> = 311) for the period 2011\u20132019. The majority of the study population was composed of people with a low level of education aged 21\u201330 years old. The prevalence of HCV, HBV, and HTLV-1\/2 infections among the study population were 10.52, 0.52, and 1.05%, respectively. No HIV infection was found among the patients. Between 2011 and 2015 the prevalence of HCV increased by over 100% and the incidence peaked in 2013. The severe hemophilia was associated with the presence of inhibitor factor (Odds Ratio [OD] 9.83; 95% IC: 3.41\u201327.62, <jats:italic>p<\/jats:italic> &amp;lt; 0.0001) or target joint (OD 6.59; 95% IC: 3.27\u201313.34, <jats:italic>p<\/jats:italic> &amp;lt; 0.0001). The presence of inhibitor was positive and significantly correlated with HCV infection (<jats:italic>r<\/jats:italic> = 1.00, <jats:italic>p<\/jats:italic> &amp;lt; 0.0001). Our results showed that HCV infection is highly prevalent in patients with hemophilia and might be involved in the development of inhibitors. Thus, these data provide new insights into the clinical and epidemiological profile of patients suffering from hemophilia in the Northern Brazilian state of Amazonas.<\/jats:p>","DOI":"10.3389\/fpubh.2022.963790","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T11:01:35Z","timestamp":1662634895000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinico-epidemiological and sociodemographic profile of patients with hemophilia in the Brazilian Amazon: High prevalence of hepatitis C infection and its possible corrrelation with inhibitor development"],"prefix":"10.3389","volume":"10","author":[{"given":"Enzo Miranda","family":"Santos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean de Melo","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anderson Nogueira","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemilson Soares","family":"Pontes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1365-2516.2006.01263.x","article-title":"Genetic diagnosis of haemophilia and other inherited bleeding disorders","volume":"12","author":"Peyvandi","year":"2006","journal-title":"Haemophilia."},{"key":"B2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.15446\/revfacmed.v65n2.57012","article-title":"Molecular study in children with hemophilia A in Colombia: analysis of intron 1 and 22 inversion using long-distance PCR technique","volume":"65","author":"Garc\u00e9s","year":"2017","journal-title":"Rev Fac Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/hae.13509","article-title":"Gaining insight into the complexity of pain in patients with haemophilia: state-of-the-art review on pain processing","volume":"24","author":"Roussel","year":"2018","journal-title":"Haemophilia."},{"key":"B4","first-page":"80","volume-title":"Manual de Hemofilia","year":"2015"},{"key":"B5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/ajh.20390","article-title":"Acquired hemophilia A: a concise review","volume":"80","author":"Franchini","year":"2005","journal-title":"Am J Hematol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2147\/JBM.S68234","article-title":"Hemophilia A in Brazil\u2014epidemiology and treatment developments","volume":"5","author":"Ferreira","year":"2014","journal-title":"J Blood Med."},{"key":"B7","year":"2020","journal-title":"Report on the Annual Global Servey 2019"},{"key":"B8","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1590\/1806-9282.64.10.872","article-title":"Challenges and perspectives in the treatment of patients with haemophilia in brasil","volume":"64","author":"Guedes","year":"2018","journal-title":"Rev Assoc Med Bras."},{"key":"B9","first-page":"27","year":"2020","journal-title":"Preval\u00eancia das Coagulopatias Heredit\u00e1rias e demais transtornos hemorr\u00e1gicos por diagn\u00f3stico, Brasil, 2019"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1046\/j.1537-2995.1999.39111160.x","article-title":"The epidemiology of virus transmission by plasma derivatives: clinical studies verifying the lack of transmission of hepatitis B and C viruses and HIV type 1","volume":"39","author":"Tabor","year":"1999","journal-title":"Transfusion"},{"key":"B11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1590\/S1020-49892003000200013","article-title":"Hemophilia care in the state of Rio de Janeiro, Brazil","volume":"13","author":"Fontes","year":"2003","journal-title":"Pan Am J Public Heal."},{"key":"B12","year":"2017","journal-title":"Perfil das Coagulopatias Heredit\u00e1rias no Brasil: 2015"},{"key":"B13","first-page":"74","author":"Silva","year":"2015","journal-title":"Avalia\u00e7\u00e3o da Qualidade de vida relacionada \u00e0 sa\u00fade em pacientes com hemofilias A e B atendidos na Funda\u00e7\u00e3o Hemominas\u2014Minas Gerais"},{"key":"B14","article-title":"Popula\u00e7\u00e3o estimada","year":"2020","journal-title":"Dir Pesqui Coord Popul e Indicadores Sociais, Estim da Popul Resid com data Ref 1o julho 2019"},{"key":"B15","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/hae.13230","article-title":"Comparing the burden of illness of haemophilia between resource-constrained and unconstrained countries: the S\u00e3o Paulo\u2013Toronto Hemophilia Study","volume":"23","author":"Carneiro","year":"2017","journal-title":"Haemophilia."},{"key":"B16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/hae.13130","article-title":"Determining the health-related quality of life in individuals with haemophilia in developing economies: results from the Brazilian population","volume":"23","author":"Salomon","year":"2017","journal-title":"Haemophilia."},{"key":"B17","year":"2010","journal-title":"Popula\u00e7\u00e3o \u00faltimo censo"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-13-60","article-title":"Prevalence and risk factors of Hepatitis C virus infection in Brazil, 2005 through 2009: a cross-sectional study","volume":"13","author":"Pereira","year":"2013","journal-title":"BMC Infect Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/jvh.12249","article-title":"Strategies to manage hepatitis C virus (HCV) disease burden","volume":"21","author":"Wedemeyer","year":"2014","journal-title":"J Viral Hepat."},{"key":"B20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/jvh.12350","article-title":"Historical epidemiology of hepatitis C virus (HCV) in selected countries","volume":"21","author":"Bruggmann","year":"2014","journal-title":"J Viral Hepat."},{"key":"B21","unstructured":"180Boletim epidemiol\u00f3gico: hepatites virais 20212021"},{"key":"B22","first-page":"57","article-title":"Perfil das Coagulopatias Heredit\u00e1rias: 2016","year":"2018"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1099\/jgv.0.000789","article-title":"Nationwide overview of the distribution of hepatitis B virus genotypes in Brazil: a 1000-sample multicentre study","volume":"98","author":"Lampe","year":"2017","journal-title":"J Gen Virol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-018-3279-2","article-title":"Determination of hepatitis B, C and D prevalence among urban and Amerindian populations from the Eastern Brazilian Amazon: a cross sectional study","volume":"18","author":"Villar","year":"2018","journal-title":"BMC Infect Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1111\/hae.13730","article-title":"Mortality of patients with haemophilia in Brazil: first report","volume":"25","author":"Jardim","year":"2019","journal-title":"Haemophilia."},{"key":"B26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/hae.13668","article-title":"Incidence and risk factors for hepatocellular cancer in individuals with haemophilia: a national inpatient sample study","volume":"25","author":"Thalappillil","year":"2019","journal-title":"Haemophilia."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1111\/hae.13427","article-title":"Hepatitis C infection in a Greek population with inherited bleeding disorders","volume":"24","author":"Giouleme","year":"2018","journal-title":"Haemophilia."},{"key":"B28","first-page":"86","author":"Pimentel","year":"2009","journal-title":"Hepatite C em pacientes hemof\u00edlicos: perfil imunol\u00f3gico e caracteriza\u00e7\u00e3o dos diferentes gen\u00f3tipos virais"},{"key":"B29","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1002\/rth2.12335","article-title":"Development of inhibitors in hemophilia A: an illustrated review","volume":"4","author":"Jardim","year":"2020","journal-title":"Res Pract Thromb Haemost."},{"key":"B30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.thromres.2018.05.027","article-title":"Risk factors for inhibitor development in severe hemophilia A","volume":"168","author":"Garagiola","year":"2018","journal-title":"Thromb Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1111\/j.1538-7836.2007.02595.x","article-title":"Treatment characteristics and the risk of inhibitor development: a multicenter cohort study among previously untreated patients with severe hemophilia A","volume":"5","author":"Gouw","year":"2007","journal-title":"J Thromb Haemost."},{"key":"B32","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1590\/0037-8682-0039-2013","article-title":"Autoantibody profile in individuals with chronic hepatitis C","volume":"46","author":"Marconcini","year":"2013","journal-title":"Rev Soc Bras Med Trop."},{"key":"B33","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/hep.1840210302","article-title":"High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C","volume":"21","author":"Clifford","year":"1995","journal-title":"Hepatology."},{"key":"B34","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/rth2.12094","article-title":"Product type and other environmental risk factors for inhibitor development in severe hemophilia A","volume":"2","author":"Peyvandi","year":"2018","journal-title":"Res Pract Thromb Haemost."},{"key":"B35","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/JCMA.0000000000000047","article-title":"Obesity and overweight in patients with hemophilia","volume":"82","author":"Chang","year":"2019","journal-title":"J Chinese Med Assoc."},{"key":"B36","doi-asserted-by":"publisher","first-page":"05","DOI":"10.1186\/1742-4690-12-S1-O5","article-title":"Estimating the number of HTLV-2 infected persons in the world","volume":"12","author":"Murphy","year":"2015","journal-title":"Retrovirology."},{"key":"B37","first-page":"25","author":"Rosadas","year":"2020","journal-title":"Preval\u00eancia da infec\u00e7\u00e3o por HTLV-1\/2 no Brasil."},{"key":"B38","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/hae.13494","article-title":"Haemophilia gene therapy: from trailblazer to gamechanger","volume":"24","author":"Evens","year":"2018","journal-title":"Haemophilia."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.963790\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T11:01:51Z","timestamp":1662634911000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.963790\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,8]]},"references-count":38,"alternative-id":["10.3389\/fpubh.2022.963790"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2022.963790","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,8]]},"article-number":"963790"}}